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In recent years, there has been a growing interest in researching and developing new antimicrobial
agents from various sources to combat microbial resistance. Therefore, a greater attention has been paid
to antimicrobial activity screening and evaluating methods. Several bioassays such as disk-diffusion, well
diffusion and broth or agar dilution are well known and commonly used, but others such as ﬂow cy-
toﬂuorometric and bioluminescent methods are not widely used because they require speciﬁed equip-
ment and further evaluation for reproducibility and standardization, even if they can provide rapid re-
sults of the antimicrobial agent's effects and a better understanding of their impact on the viability and
cell damage inﬂicted to the tested microorganism. In this review article, an exhaustive list of in vitro
antimicrobial susceptibility testing methods and detailed information on their advantages and limita-
tions are reported.
& 2015 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. This is an open access article
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i).1. Introduction
Antimicrobial susceptibility testing can be used for drug dis-
covery, epidemiology and prediction of therapeutic outcome. Inis is an open access article under the CC BY-NC-ND license
M. Balouiri et al. / Journal of Pharmaceutical Analysis 6 (2016) 71–7972this review, we focused on the use of antimicrobial testing
methods for the in vitro investigation of extracts and pure drugs as
potential antimicrobial agents.
After the revolution in the “golden era”, when almost all groups
of important antibiotics (tetracyclines, cephalosporins, aminogly-
cosides and macrolides) were discovered and the main problems
of chemotherapy were solved in the 1960s, the history repeats
itself nowadays and these exciting compounds are in danger of
losing their efﬁcacy because of the increase in microbial resistance
[1]. Currently, its impact is considerable with treatment failures
associated with multidrug-resistant bacteria and it has become a
global concern to public health [2,3].
For this reason, discovery of new antibiotics is an exclusively
important objective. Natural products are still one of the major
sources of new drug molecules today. They are derived from
prokaryotic bacteria, eukaryotic microorganisms, plants and
various animal organisms. Microbial and plant products occupy
the major part of the antimicrobial compounds discovered until
now [4].
Plants and other natural sources can provide a huge range of
complex and structurally diverse compounds. Recently, many re-
searchers have focused on the investigation of plant and microbial
extracts, essential oils, pure secondary metabolites and new syn-
thetized molecules as potential antimicrobial agents [5–7]. How-
ever, when we reviewed the published articles on the anti-
microbial effect of these natural products, the comparison be-
tween results is often difﬁcult, because of the use of different non-
standardized approaches inoculum preparation techniques,
inoculum size, growth medium, incubation conditions and end-
points determination.
The fact that a plant extract exhibits antimicrobial activity is of
interest, but this preliminary part of data should be trustworthy
and allow researchers to compare results, avoiding work in which
researchers use the antimicrobial activity investigation only as a
complement to a phytochemical study.
A variety of laboratory methods can be used to evaluate or
screen the in vitro antimicrobial activity of an extract or a pure
compound. The most known and basic methods are the disk-dif-
fusion and broth or agar dilution methods. Other methods are
used especially for antifungal testing, such as poisoned food
technique. To further study the antimicrobial effect of an agent in
depth, time-kill test and ﬂow cytoﬂuorometric methods are re-
commended, which provide information on the nature of the in-
hibitory effect (bactericidal or bacteriostatic) (time-dependent or
concentration-dependent) and the cell damage inﬂicted to the test
microorganism.
Owing to the new attraction to the properties of new anti-
microbial products like combating multidrug-resistant bacteria, it
is important to develop a better understanding of the current
methods available for screening and/or quantifying the anti-
microbial effect of an extract or a pure compound for its applica-
tions in human health, agriculture and environment. Therefore, in
this review, the techniques for evaluating the in vitro antimicrobial
activity were discussed in detail.2. Diffusion methods
2.1. Agar disk-diffusion method
Agar disk-diffusion testing developed in 1940 [8], is the ofﬁcial
method used in many clinical microbiology laboratories for rou-
tine antimicrobial susceptibility testing. Nowadays, many accepted
and approved standards are published by the Clinical and La-
boratory Standards Institute (CLSI) for bacteria and yeasts testing
[9,10]. Although not all fastidious bacteria can be tested accuratelyby this method, the standardization has been made to test certain
fastidious bacterial pathogens like streptococci, Haemophilus in-
ﬂuenzae, Haemophilus parainﬂuenzae, Neisseria gonorrhoeae and
Neisseria meningitidis, using speciﬁc culture media, various in-
cubation conditions and interpretive criteria for inhibition zones
[9].
In this well-known procedure, agar plates are inoculated with a
standardized inoculum of the test microorganism. Then, ﬁlter
paper discs (about 6 mm in diameter), containing the test com-
pound at a desired concentration, are placed on the agar surface.
The Petri dishes are incubated under suitable conditions. Gen-
erally, antimicrobial agent diffuses into the agar and inhibits ger-
mination and growth of the test microorganism and then the
diameters of inhibition growth zones are measured (Fig. 1A). Ta-
ble 1 shows the growth media, temperature, period of incubation
and inoculum size required by CLSI standards.
Antibiogram provides qualitative results by categorizing bac-
teria as susceptible, intermediate or resistant [11]. Therefore, it is a
typing tool based on the resistance phenotype of the microbial
strain tested, its outcomes also guide clinicians in the appropriate
selection of initial empiric treatments, and antibiotics used for
individual patients in particular situations [12]. However, since the
bacterial growth inhibition does not mean the bacterial death, this
method cannot distinguish bactericidal and bacteriostatic effects.
Moreover, the agar disk-diffusion method is not appropriate to
determine the minimum inhibitory concentration (MIC), as it is
impossible to quantify the amount of the antimicrobial agent
diffused into the agar medium. Nevertheless, an approximate MIC
can be calculated for some microorganisms and antibiotics by
comparing the inhibition zones with stored algorithms [13].
Nevertheless, disk-diffusion assay offers many advantages over
other methods: simplicity, low cost, the ability to test enormous
numbers of microorganisms and antimicrobial agents, and the
ease to interpret results provided. Moreover, several studies have
demonstrated the great interest in patients who suffer from bac-
terial infection of an antibiotherapy based on the antibiogram of
the causative agent [14]. This fact is due to the good correlation
between the in vitro data and the in vivo evolution [12].
Before its standardization, disk-diffusion method has been al-
ready used to test posaconazole against ﬁlamentous fungi [15],
micafungin against Aspergillus [16], and caspofungin against As-
pergillus and Fusarium [17]. Currently, a standardized antifungal
disk-diffusion approach is used to test non-dermatophyte ﬁla-
mentous fungi [18]. The culture medium, inoculum size and in-
cubation conditions are mentioned in Table 1 [19].
The above-mentioned advantages of this method, mainly sim-
plicity and low cost, have contributed to its common use for the
antimicrobial screening of plant extracts, essential oils and other
drugs [20–23].
2.2. Antimicrobial gradient method (Etest)
The antimicrobial gradient method combines the principle of
dilution methods with that of diffusion methods in order to de-
termine the MIC value. It is based on the possibility of creating a
concentration gradient of the antimicrobial agent tested in the
agar medium. The Etests (BioMérieux) is a commercial version of
this technique. In the procedure, a strip impregnated with an in-
creasing concentration gradient of the antimicrobial agent from
one end to the other is deposited on the agar surface, previously
inoculated with the microorganism tested.
This method is used for the MIC determination of antibiotics,
antifungals and antimycobacterials [24]. MIC value is determined
at the intersection of the strip and the growth inhibition ellipse. It
is simple to implement; thus, it is routinely used to meet the de-
mands of clinicians. However, Etests strips cost about $2–3 each.
Fig. 1. Agar diffusion methods: (A) disk-diffusion method of microbial extract using C. albicans as test microorganism, (B) agar well diffusion method of essential oil using
Aspergillus niger as test microorganism, and (C) agar plug diffusion method of Bacillus sp. against C. albicans.
Table 1
Culture media, microbial inoculum size and incubation conditions for antimicrobial susceptibility testing methods as recommended by CLSI.
Methods Microorganism Growth medium Final inoculum size Incubation
temperature (°C)
Incubation time (h) Ref.
Disk-diffusion method Bacteria MHA (0.5 McFarland) (1–2)
108 CFU/mL
3572 16–18 M02-A [9]
Yeast MHAþGMBa (0.5 McFarland) (1–5)
106 CFU/mL
3572 20–24 M44-A [10]
Molds Non-supplemented MHA (0.4–5)106 CFU/mL – – M51-A [18]
Broth microdilution Bacteria MHB 5105 CFU/mL 3572 20 M07-A [56]
Yeast RPMI 1640b (0.5–2.5)103 CFU/mL 35 24–48 M27-A [69]
Molds RPMI 1640b (0.4–5)104 CFU/mL 35 48 for most fungi M38-A [70]
Broth macrodilution Bacteria MHB 5105 CFU/mL 3572 20 M07-A [56]
Yeast RPMI 1640b (0.5–2.5)103 CFU/mL 35 46–50 M27-A [69]
Molds RPMI 1640b (0.4–5)104 CFU/mL 35 48 for most fungi M38-A [70]
Agar dilution Bacteria MHA 104 CFU/spot 3572 16–20 M07-A [56]
Time-kill test Bacteria MHB 5105 CFU/mL 3572 0, 4, 18, and 24 M26-A [75]
MHA: Mueller Hinton Agar. MHB: Mueller Hinton Broth.
a GMB: the medium was supplemented with 2% glucose and 0.5 mg/mL methylene blue.
b RPMI 1640: Roswell Park Memorial Institute medium (with glutamine, without bicarbonate, and with phenol red as a pH indicator) was 1640, buffered to pH 7.0 with
MOPS (morpholine propane sulfonic acid) at 0.165 M.
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tested [11].
Several previous studies have shown a good correlation be-
tween the MIC values determined by Etest and those obtained by
broth dilution or agar dilution method [25–27]. This technique can
also be performed to investigate the antimicrobial interaction
between two drugs [28]. To study the combined effect of two
antibiotics, an Etest strip, impregnated with a ﬁrst antibiotic, is
placed on a pre-inoculated agar plate surface. After one hour, the
strip is removed and replaced by another one impregnated with a
second antibiotic. The synergy is detected by a decrease of the MIC
of the combination by at least two dilutions compared to that ofthe most active antibiotic tested alone [29]. Also for the same
purpose, the Etest strips can be deposited on the agar medium in a
cross formation with a 90° angle at the intersection between the
scales at the respective MICs for the microorganism tested [30].
Then, after incubation, the fractional inhibitory concentration in-
dex (FICI) can be calculated using the following formula:
∑ = ( ) + ( )FICI FIC A FIC B
( ) = ( ) ( )where FIC A
MIC A in combination
MIC A alone
and ( ) = ( ) ( )FIC B
MIC B in combination
MIC B alone
Synergy was deﬁned by FICI r0.5 and antagonism by FICI 44.
The FICI between 0.5 and 1 was interpreted as addition and be-
tween 1 and 4 as indifference [31].
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Further diffusion methods are used in the microbiology re-
search laboratories to screen extracts, fractions or pure substances
for their antimicrobial potency or to investigate the antagonism
between microorganisms. Among these methods, the most com-
mon are listed below.
2.3.1. Agar well diffusion method
Agar well diffusion method is widely used to evaluate the an-
timicrobial activity of plants or microbial extracts [32,33]. Similarly
to the procedure used in disk-diffusion method, the agar plate
surface is inoculated by spreading a volume of the microbial in-
oculum over the entire agar surface. Then, a hole with a diameter
of 6 to 8 mm is punched aseptically with a sterile cork borer or a
tip, and a volume (20–100 mL) of the antimicrobial agent or extract
solution at desired concentration is introduced into the well. Then,
agar plates are incubated under suitable conditions depending
upon the test microorganism. The antimicrobial agent diffuses in
the agar medium and inhibits the growth of the microbial strain
tested (Fig. 1B).
2.3.2. Agar plug diffusion method
Agar plug diffusion method is often used to highlight the an-
tagonism between microorganisms [34,35], and the procedure is
similar to that used in the disk-diffusion method. It involves
making an agar culture of the strain of interest on its appropriate
culture medium by tight streaks on the plate surface. During their
growth, microbial cells secrete molecules which diffuse in the agar
medium. After incubation, an agar-plot or cylinder is cut asepti-
cally with a sterile cork borer and deposited on the agar surface of
another plate previously inoculated by the test microorganism.
The substances diffuse from the plug to the agar medium. Then,
the antimicrobial activity of the microbial secreted molecules is
detected by the appearance of the inhibition zone around the agar
plug (Fig. 1C).
2.3.3. Cross streak method
Cross streak method is used to rapidly screen microorganisms
for antagonism [36]. The microbial strain of interest is seeded by a
single streak in the center of the agar plate. After an incubation
period depending upon the microbial strain, the plate is seeded
with the microorganisms tested by single streak perpendicular to
the central streak. After further incubation, the antimicrobial in-
teractions are analyzed by observing the inhibition zone size.
2.3.4. Poisoned food method
Poisoned food method is mostly used to evaluate the antifungal
effect against molds [37–39]. The antifungal agent or the extract is
incorporated into the molten agar at a desired ﬁnal concentration
and mixed well. Then, the medium is poured into Petri dishes.
After overnight pre-incubation, the inoculation can be done by a
mycelia disc ranging from 2 to 5 mm, which is deposited in the
center of the plate. After further incubation under suitable con-
ditions for the fungal strain tested, the diameters of fungal growth
in control and sample plates are measured, and the antifungal
effect is estimated by the following formula:
( )=(( − ) ) ×Antifungal activity % Dc Ds /Dc 100
Where Dc is the diameter of growth in control plate and Ds is
the diameter of growth in the plate containing tested antifungal
agent. Sporulation can be also compared to the control.
Generally, when standardization of the method used fails, the
researcher must carry a positive control with known antimicrobial
molecule to compare the results found and assert theexperimental approach right.3. Thin-layer chromatography (TLC)–bioautography
In 1946, Goodall and Levi [40] combined paper chromato-
graphy method (PC) with contact bioautography to detect different
penicillins for their determination. Thereafter, Fischer and Lautner
[41] introduced TLC in the same ﬁeld. This technique combines TLC
with both biological and chemical detection methods. Several
works have been done on the screening of organic extracts, mainly
plant extracts, for antibacterial and antifungal activity by TLC–
bioautography [42,43]. As shown below, three bioautographic
techniques, i.e., agar diffusion, direct bioautography and agar-
overlay assay, have been described for the investigation of anti-
microbial compounds by this approach.
3.1. Agar diffusion
Also known as agar contact method, it is the least-employed
one of the techniques. It involves the transfer by diffusion of the
antimicrobial agent from the chromatogram (PC or TLC) to an agar
plate previously inoculated with the microorganism tested. After
some minutes or hours to allow diffusion, the chromatogram is
removed and the agar plate is incubated. The growth inhibition
zones appear in the places, where the antimicrobial compounds
contact with the agar layer [44].
3.2. Direct bioautography
Direct bioautography is the most applied method among these
three methods. The developed TLC plate is dipped into or sprayed
with a microbial suspension. Then, bioautogram is incubated at
25 °C for 48 h under humid condition [45]. For visualization of the
microbial growth, tetrazolium salts are frequently used. These salts
undergo a conversion to corresponding intensely colored for-
mazan by the dehydrogenases of living cells [46,47]. p-Iodoni-
trotetrazolium violet is the most suitable detection reagent
[44,48]. These salts are sprayed onto the bioautogram, which is
reincubated at 25 °C for 24 h [49] or at 37 °C for 3–4 h [5]. The
Mueller Hinton Broth supplemented with agar has been re-
commended to give a medium sufﬁcient ﬂuid to allow a best ad-
herence to the TLC plate and maintain appropriate humidity for
bacterial growth [50].
Direct bioautography may be utilized with either fungi or
bacteria. It is the easiest technique for the detection of antifungal
substances, and also gives consistent results for spore-producing
fungi such as Aspergillus, Penicillium and Cladosporium [51,52]. For
bacteria, Bacillus subtilis, Staphylococcus aureus and Escherichia coli
strains are frequently used to identify antibacterial compounds
[42,53].
3.3. Agar overlay bioassay
Also known as immersion bioautography, it is a hybrid of the
both previous methods. TLC plate is covered with a molten seeded
agar medium. In order to allow a good diffusion of the tested
compounds into the agar medium, the plates can be placed at low
temperature for few hours before incubation. After incubation
under suitable conditions depending upon the test microorganism,
staining can be made with tetrazolium dye. Like direct bioauto-
graphy, this method can be applied to all microorganisms such as
Candida albicans [54] and molds [43]. It provides well-deﬁned
growth inhibition zones and is not sensitive to contamination [44].
Overall, TLC–bioautography is a simple, effective and in-
expensive technique for the separation of a complex mixture, and
M. Balouiri et al. / Journal of Pharmaceutical Analysis 6 (2016) 71–79 75at the same time, it localizes the active constituents on the TLC
plate. Therefore, it can be performed both in sophisticated la-
boratories and small laboratories which only have access to a
minimum of equipment [44]. Although having sophisticated on-
line high performance liquid chromatography coupled bioassay,
which is becoming increasingly popular as the method of choice
for a ﬁnal clean-up of extractive fractions to obtain pure com-
pounds, the TLC–bioautography offers a rapid technique for the
screening of a large number of samples for bioactivity and in the
bioactivity-guided fractionation [45]. It can be used for detection
of antimicrobials in environmental and food samples as well as for
searching for new antimicrobial drugs.4. Dilution methods
Dilution methods are the most appropriate ones for the de-
termination of MIC values, since they offer the possibility to esti-
mate the concentration of the tested antimicrobial agent in the
agar (agar dilution) or broth medium (macrodilution or micro-
dilution). Either broth or agar dilution method may be used to
quantitatively measure the in vitro antimicrobial activity against
bacteria and fungi. MIC value recorded is deﬁned as the lowest
concentration of the assayed antimicrobial agent that inhibits the
visible growth of the microorganism tested, and it is usually ex-
pressed in mg/mL or mg/L. There are many approved guidelines for
dilution antimicrobial susceptibility testing of fastidious or non-
fastidious bacteria, yeast and ﬁlamentous fungi. The most re-
cognized standards are provided by the CLSI and the European
Committee on Antimicrobial Susceptibility Testing (EUCAST). As
advised, these guidelines provide a uniform procedure for testing
that is practical to perform in most clinical microbiology labora-
tories. The development of such methodologic standards does not
guarantee the clinical relevance of such testing. Nevertheless, it
does allow the bioassay to be performed in a standardized ap-
proach in order to evaluate the clinical relevance of results [55].
4.1. Broth dilution method
Broth micro- or macro-dilution is one of the most basic anti-
microbial susceptibility testing methods. The procedure involves
preparing two-fold dilutions of the antimicrobial agent (e.g. 1, 2, 4,Fig. 2. Broth microdilution method of plant extract aga8, 16 and 32 mg/mL) in a liquid growth medium dispensed in tubes
containing a minimum volume of 2 mL (macrodilution) or with
smaller volumes using 96-well microtitration plate (microdilution)
(Fig. 2). Then, each tube or well is inoculated with a microbial
inoculum prepared in the same medium after dilution of stan-
dardized microbial suspension adjusted to 0.5 McFarland scale
(Fig. 3). After well-mixing, the inoculated tubes or the 96-well
microtitration plate are incubated (mostly without agitation) un-
der suitable conditions depending upon the test microorganism
(Table 1). The experimental methodology to perform accurately
the microdilution is schematized in Fig. 4.
The MIC is the lowest concentration of antimicrobial agent that
completely inhibits growth of the organism in tubes or micro-
dilution wells as detected by the unaided eye [56]. Unlike micro-
dilution method, the main disadvantages of the macrodilution
method are the tedious, manual undertaking, risk of errors in the
preparation of antimicrobial solutions for each test, and the
comparatively large amount of reagents and space required [11].
Thus, the reproducibility and the economy of reagents and space
that occurs due to the miniaturization of the test are the major
advantages of the microdilution method. Nevertheless, the ﬁnal
result is signiﬁcantly inﬂuenced by approach, which must be
carefully controlled if reproducible results (intralaboratory and
interlaboratory) are to be attained [56]. For the determination of
MIC endpoint, viewing devices can facilitate reading microdilution
tests and recording results with high ability to discern growth in
the wells. Moreover, several colorimetric methods based on the
use of dye reagents have been developed. Tetrazolium salts, 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
and 2,3-bis {2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-
tetrazolium-hydroxide} (XTT), are often used in the MIC endpoint
determination for both antifungal and antibacterial microdilution
assays [57–60]. The Alamar blue dye (resazurin), an effective
growth indicator, can also be used for this purpose [61–64].
It is well known that the inoculum size [65], the type of growth
medium [66], the incubation time and the inoculum preparation
method can inﬂuence MIC values [67,68]. Therefore, broth dilution
has been standardized by CLSI for testing bacteria that grow
aerobically [56], yeast [69] and ﬁlamentous fungi [70]. The EUCAST
broth dilution method is principally similar to that of CLSI with
modiﬁcations usually concerning some of the test parameters such
as inoculum preparation, inoculum size, and the MIC readinginst B. subtilis using resazurin as growth indicator.
Fig. 3. 0.5 McFarland microbial inoculum preparation by the direct colony suspension as recommended by CLSI guidelines.
Fig. 4. Broth microdilution for antibacterial testing as recommended by CLSI protocol.
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EUCAST guidelines [71].
As regards to the conidium and spores forming fungi, the mi-
crodilution standardized by CLSI involves an inoculum of spores
adjusted spectrophotometrically to 0.4104–5104 CFU/mL.
However, in the EUCAST assay, the inoculum can be adjusted to
(2–5)105 CFU/mL by haemocytometer counting [72]. Numerous
studies showed the importance of inoculum preparation by hae-
mocytometer counting for reproducible and suitable preparation
independent of the color and size of conidia [68,73,74].
The determination of minimum bactericidal concentration
(MBC) or minimum fungicidal concentration (MFC), also known as
the minimum lethal concentration (MLC), is the most common
estimation of bactericidal or fungicidal activity. The MBC is deﬁned
as the lowest concentration of antimicrobial agent needed to kill
99.9% of the ﬁnal inoculum after incubation for 24 h under a
standardized set of conditions described in document M26-A [75],
in which the MBC can be determined after broth macrodilution or
microdilution by sub-culturing a sample from wells or tubes,
yielding a negative microbial growth after incubation on the sur-
face of non-selective agar plates to determine the number of sur-
viving cells (CFU/mL) after 24 h of incubation. The bactericidal
endpoint (MBC) has been subjectively deﬁned as the lowest con-
centration, at which 99.9% of the ﬁnal inoculum is killed [75]. MFC
is also deﬁned as the lowest concentration of the drug that yields98%–99.9% killing effect as compared to the initial inoculum [71].
Several studies have been carried out for evaluation of different
test parameters for determination of MFC of various drugs against
Candida isolates [76], Aspergillus [77] and other molds [78].
4.2. Agar dilution method
The agar dilution method involves the incorporation of varying
desired concentrations of the antimicrobial agent into an agar
medium (molten agar medium), habitually using serial two-fold
dilutions, followed by the inoculation of a deﬁned microbial in-
oculum onto the agar plate surface. The MIC endpoint is recorded
as the lowest concentration of antimicrobial agent that completely
inhibits growth under suitable incubation conditions (Table 1).
This technique is suitable for both antibacterial and antifungal
susceptibility testing. If multiple isolates are being tested against a
single compound, or if the compound (or extract) tested masks the
detection of microbial growth in the liquid medium with its
coloring, agar dilution method is often preferred to broth dilution
for the MIC determination. Nowadays, commercially produced
inoculum replicators are available and can transfer between 32
and 60 different bacterial inocula to each agar plate. Agar dilution
is often recommended as a standardized method for fastidious
organisms [79] such as anaerobes and Helicobacter species. It has
been also used for antifungal agent-drugs combinations against
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This method presents a good correlation with Etest mostly for
antibacterial testing against both Gram-positive and Gram-nega-
tive bacteria. Moreover, category comparisons of agar dilution,
disk-diffusion and broth microdilution methods give excellent
results [25].5. Time-kill test (time-kill curve)
Time-kill test is the most appropriate method for determining
the bactericidal or fungicidal effect. It is a strong tool for obtaining
information about the dynamic interaction between the anti-
microbial agent and the microbial strain. The time-kill test reveals
a time-dependent or a concentration-dependent antimicrobial
effect [55].
For bacteria, this test has been well standardized and described
in M26-A document of CLSI [75]. It is performed in broth culture
medium using three tubes containing a bacterial suspension of
5105 CFU/mL. The ﬁrst and the second tubes contain the mole-
cule or the extract tested usually at ﬁnal concentrations of
0.25MIC and 1MIC, and the third one is considered as the
growth control. The incubation is done under suitable conditions
for varied time intervals (0, 4, 6, 8, 10, 12 and 24 h) [21,55]. Then,
the percentage of dead cells is calculated relatively to the growth
control by determining the number of living cells (CFU/mL) of each
tube using the agar plate count method. Generally, the bactericidal
effect is obtained with a lethality percentage of 90% for 6 h, which
is equivalent to 99.9% of lethality for 24 h [21]. In addition, this
method can be used to determine synergism or antagonism be-
tween drugs (two or more) in combinations [28,55]. Similarly,
several antifungal substances were studied by this method [84,85].6. ATP bioluminescence assay
ATP bioluminescence assay is based on the capacity to measure
adenosine triphosphate (ATP) produced by bacteria or fungi. As
ATP is the chemical form of energy of all living cells, it is present in
more or less a constant amount in a cell. Therefore, its quantiﬁ-
cation is used to estimate the microbial population in a sample. D-
luciferin in the presence of the ATP undergoes conversion by lu-
ciferase to oxyluciferin that generates light. The quantity of the
emitted light is measured by a luminometer and expressed as
relative light unit (RLU) which can be converted into RLU/mole of
ATP. Thus, there is a linear relationship between cell viability and
luminescence measured.
Bioluminescence assay has a large range of applications, such
as cytotoxicity test [86], in situ evaluation of the impact of bioﬁlms
in situ [87], and drug screening on Leishmania [88]. Moreover, It
has been used by several authors for antibacterial testing [89],
antimycobacterial testing [90,91], antifungal against yeast [92] and
molds [93]. The rapidity is the major advantage of this technique
that provides quantitative results. Indeed it has been demon-
strated that this technique can provide results in 3–5 days for
antimycobacterial tests [90,91] in comparison with the conven-
tional dilution technique, which requires 3–4 weeks of incubation
[90,91]. Bioluminescence assay also has the advantage of being
used for antimicrobial testing in vivo or in situ [94].7. Flow cytoﬂuorometric method
Several years ago, the usefulness of ﬂow cytometry for sus-
ceptibility testing of microorganisms was suggested. Thus, many
authors investigated the antibacterial and antifungal activities ofmany drugs using this methodology [95–98]. The rapid detection
of damaged cells by this approach depends on the use of appro-
priate dyes staining [96,99]. Therefore, propidium iodide (PI), a
ﬂuorescent and intercalating agent, is widely used as DNA stain
[96]. Several studies were reported on the effectiveness of ﬂow
cytometer as a tool for antibacterial testing of essential oils against
Listeria monocytogenes, using combined staining with PI for
membrane damage evaluation and carboxyﬂuorescein diacetate
(cFDA) for esterase activity detection [95]. Consequently, in addi-
tion to the lysed cells, three subpopulations (dead, viable and in-
jured cells) can be clearly discriminated by this method. The in-
jured cells are described as stressed cells exhibiting cellular com-
ponents damages and subsequent impairment of reproductive
growth [100]. Quantiﬁcation of injured cells has an interesting
outcome in food microbiology, as this subpopulation might be
critical if cell recovery becomes possible, such as in temperature
abuse conditions during food storage [95]. Indeed, ﬂow cyto-
ﬂuorometric method allows the detection of antimicrobial re-
sistance and estimates the impact of the molecule tested on the
viability and cell damage of the tested microorganism [101].
Moreover, it gives reproducible results rapidly (2–6 h compared to
24–72 h for the microdilution method) [96]. However, the wide-
spread use of this methodology for antimicrobial susceptibility
testing currently appears unlikely due to the inaccessibility of the
required ﬂow cytometry equipment in various laboratories.8. Conclusion
Currently, microbial infections have become an important
clinical threat, with signiﬁcant associated morbidity and mortality
which is mainly due to the development of microbial resistance to
the existing antimicrobial agents. Therefore, methods for anti-
microbial susceptibility testing and discovering novel anti-
microbial agents have been extensively used and continue to be
developed. Some techniques were subjected to standardization by
the CLSI and EUCAST, marking the major remarkable steps on this
ﬁeld. However, when testing natural products, some modiﬁcations
of the standardized protocols are often requested. Thus, it is im-
perative to be careful not to change the basics of microbiology by
diluting the culture media and using a highly concentrated
inoculum. Moreover, if we consider the use of solvents that may
affect the growth of the microorganism tested, we can say that
making minor methodological adaptations to standardized pro-
tocols can be a solution to ensure accurate experimental approach
and allow other researchers to compare results.References
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